These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32505875)

  • 21. Antibiotic resistance in low- and middle-income countries: current practices and its global implications.
    Al Meslamani AZ
    Expert Rev Anti Infect Ther; 2023; 21(12):1281-1286. PubMed ID: 37804134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper.
    Rzewuska M; Charani E; Clarkson JE; Davey PG; Duncan EM; Francis JJ; Gillies K; Kern WV; Lorencatto F; Marwick CA; McEwen J; Möhler R; Morris AM; Ramsay CR; Rogers Van Katwyk S; Skodvin B; Smith I; Suh KN; Grimshaw JM;
    Clin Microbiol Infect; 2019 Feb; 25(2):163-168. PubMed ID: 30195471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ensuring access to 'access' antibiotics: an imminent consideration for sustainable antimicrobial stewardship in the developing world.
    Kakkar AK; Shafiq N; Malhotra S
    Infect Dis (Lond); 2019 May; 51(5):395-398. PubMed ID: 30776933
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model.
    D'Agata EMC; Tran D; Bautista J; Shemin D; Grima D
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1389-1397. PubMed ID: 30139804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial stewardship in low- and middle-income countries: Developing a broader perspective through an ethical analysis.
    Sinha I; Dayama S
    Indian J Med Ethics; 2024; IX(1):35-40. PubMed ID: 38375646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries.
    Porter G; Joshi J; Bhullar L; Kotwani A;
    BMJ Glob Health; 2020; 5(1):e001864. PubMed ID: 32133168
    [No Abstract]   [Full Text] [Related]  

  • 27. Hospital-Based Antimicrobial Stewardship Programs Used in Low- and Middle-Income Countries: A Scoping Review.
    Setiawan E; Abdul-Aziz MH; Roberts JA; Cotta MO
    Microb Drug Resist; 2022 May; 28(5):566-584. PubMed ID: 35333607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Antimicrobial Stewardship in Low- and Middle-Income Countries.
    Gyssens IC; Wertheim HF
    Front Public Health; 2020; 8():617000. PubMed ID: 33344409
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications.
    Pierce J; Stevens MP
    Int J Infect Dis; 2021 Dec; 113():103-108. PubMed ID: 34624517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and opportunities for antimicrobial stewardship in resource-rich and resource-limited countries.
    Hijazi K; Joshi C; Gould IM
    Expert Rev Anti Infect Ther; 2019 Aug; 17(8):621-634. PubMed ID: 31282277
    [No Abstract]   [Full Text] [Related]  

  • 31. Lessons from the field: Supporting infection prevention and control and antimicrobial stewardship in Amman, Jordan.
    Shallal A; Jarrah J; Prentiss T; Suleyman G; Veve MP; Banat A; Zervos J; Mousa AB; Msadeh L; Zerriouh Thneibat FM; Zervos M; Al-Raiby J; Alsawalha L; Zayed B
    J Infect Public Health; 2023 Dec; 16 Suppl 1():78-81. PubMed ID: 37945495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are antimicrobial stewardship programs effective strategies for preventing antibiotic resistance? A systematic review.
    Bertollo LG; Lutkemeyer DS; Levin AS
    Am J Infect Control; 2018 Jul; 46(7):824-836. PubMed ID: 29472107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next.
    Kronman MP; Banerjee R; Duchon J; Gerber JS; Green MD; Hersh AL; Hyun D; Maples H; Nash CB; Parker S; Patel SJ; Saiman L; Tamma PD; Newland JG
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):241-248. PubMed ID: 29267871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-Resistant Infections in the Developing World.
    Singh P; Holmen J
    Pediatr Clin North Am; 2022 Feb; 69(1):141-152. PubMed ID: 34794671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers, facilitators, perceptions and impact of interventions in implementing antimicrobial stewardship programs in hospitals of low-middle and middle countries: a scoping review.
    Harun MGD; Sumon SA; Hasan I; Akther FM; Islam MS; Anwar MMU
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):8. PubMed ID: 38263235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial Stewardship and Antimicrobial Resistance.
    Rice LB
    Med Clin North Am; 2018 Sep; 102(5):805-818. PubMed ID: 30126572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies.
    Ohl CA; Dodds Ashley ES
    Clin Infect Dis; 2011 Aug; 53 Suppl 1():S23-8; quiz S29-30. PubMed ID: 21795725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.
    Klein EY; Milkowska-Shibata M; Tseng KK; Sharland M; Gandra S; Pulcini C; Laxminarayan R
    Lancet Infect Dis; 2021 Jan; 21(1):107-115. PubMed ID: 32717205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.
    Thabit AK; Crandon JL; Nicolau DP
    Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial stewardship programs.
    Leuthner KD; Doern GV
    J Clin Microbiol; 2013 Dec; 51(12):3916-20. PubMed ID: 23926165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.